Hookipa Pharma (HOOK) Stock Chart & Stock Price History → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free HOOK Stock Alerts $0.79 +0.04 (+5.31%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Hookipa Pharma Stock Price Performance5 Day Performance+1.78%1 Month Performance-13.50%3 Month Performance+3.10%6 Month Performance+38.09%Year-To-Date Performance-1.98%1 Year Performance-29.73% Receive HOOK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. HOOK Stock Chart for Sunday, June, 2, 2024 HOOK Chart by TradingView Hookipa Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.75$0.79+5.63%$0.80$0.77325,343 shs$78.57 million05/30/2024$0.75$0.75+0.23%$0.77$0.73398,593 shs$74.38 million05/29/2024$0.78$0.75-3.86%$0.78$0.741.07 million shs$74.21 million05/28/2024$0.80$0.78-2.49%$0.84$0.78719,229 shs$77.19 million05/27/2024$0.80$0.80$1.05$0.792.28 million shs$79.16 million05/24/2024$1.04$0.80-23.08%$1.05$0.792.27 million shs$79.16 million Get the Latest News and Ratings for HOOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.98$1.04+6.12%$1.05$0.961.62 million shs$102.91 million05/22/2024$0.86$0.98+14.34%$0.99$0.862.16 million shs$96.97 million05/21/2024$0.86$0.86-0.22%$0.89$0.83566,986 shs$84.81 million05/20/2024$0.82$0.86+5.35%$0.87$0.82451,481 shs$85.00 million05/17/2024$0.81$0.82+0.54%$0.84$0.80282,004 shs$80.68 million05/16/2024$0.86$0.81-5.59%$0.87$0.81661,885 shs$80.25 million05/15/2024$0.82$0.86+4.15%$0.86$0.82383,672 shs$85.00 million05/14/2024$0.77$0.82+7.63%$0.83$0.76468,432 shs$81.61 million05/13/2024$0.77$0.77-0.22%$0.79$0.74344,003 shs$75.83 million05/10/2024$0.80$0.77-4.00%$0.81$0.74623,570 shs$75.99 million05/09/2024$0.80$0.80$0.85$0.79600,630 shs$79.16 million05/08/2024$0.83$0.80-3.26%$0.85$0.79523,931 shs$79.16 million05/07/2024$0.88$0.83-6.05%$0.88$0.80843,695 shs$81.83 million05/06/2024$0.93$0.88-5.36%$0.94$0.85457,034 shs$87.11 million05/03/2024$0.92$0.93+1.34%$0.95$0.91323,290 shs$92.04 million05/02/2024$0.90$0.92+2.10%$0.93$0.89426,779 shs$90.83 million05/01/2024$0.89$0.90+1.32%$0.92$0.85417,184 shs$88.96 million04/30/2024$0.94$0.89-5.71%$0.97$0.88693,624 shs$87.80 million04/29/2024$0.89$0.94+5.34%$1.03$0.902.26 million shs$93.11 million04/26/2024$0.81$0.89+10.82%$0.95$0.782.89 million shs$88.39 million04/25/2024$0.85$0.81-5.16%$0.84$0.751.84 million shs$79.76 million04/24/2024$0.77$0.85+11.11%$0.87$0.7310.42 million shs$84.11 million04/23/2024$0.71$0.77+8.20%$0.80$0.72789,514 shs$75.70 million04/22/2024$0.73$0.71-3.55%$0.75$0.70855,304 shs$69.96 million04/19/2024$0.76$0.73-4.17%$0.80$0.73433,007 shs$72.53 million04/18/2024$0.76$0.76+0.31%$0.80$0.75172,806 shs$75.69 million04/17/2024$0.81$0.76-5.85%$0.82$0.75495,768 shs$75.45 million04/16/2024$0.76$0.81+6.57%$0.83$0.74481,944 shs$80.14 million04/15/2024$0.79$0.76-3.37%$0.90$0.73666,042 shs$75.20 million04/12/2024$0.81$0.79-2.32%$0.85$0.71923,970 shs$77.82 million04/11/2024$0.83$0.81-2.98%$0.83$0.79212,414 shs$79.68 million04/10/2024$0.84$0.83-1.37%$0.87$0.80423,938 shs$82.12 million04/09/2024$0.85$0.84-1.01%$0.90$0.821.03 million shs$83.26 million04/08/2024$0.75$0.85+12.84%$0.87$0.751.15 million shs$84.11 millionWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are.04/05/2024$0.75$0.75+0.84%$0.75$0.72519,331 shs$74.54 million04/04/2024$0.77$0.75-2.86%$0.79$0.74460,190 shs$73.92 million04/03/2024$0.76$0.77+1.18%$0.79$0.74979,233 shs$76.09 million04/02/2024$0.72$0.76+5.04%$0.76$0.70744,797 shs$75.20 million04/01/2024$0.71$0.72+1.62%$0.74$0.71223,562 shs$60.74 million03/29/2024$0.71$0.71$0.74$0.71376,099 shs$59.77 million03/28/2024$0.72$0.71-1.17%$0.74$0.71375,874 shs$59.77 million03/27/2024$0.72$0.72+0.19%$0.73$0.70416,349 shs$60.48 million03/26/2024$0.70$0.72+2.33%$0.73$0.70130,298 shs$60.36 million03/25/2024$0.71$0.70-1.20%$0.74$0.70388,723 shs$58.98 million03/22/2024$0.72$0.71-1.80%$0.75$0.71609,195 shs$59.70 million03/21/2024$0.71$0.72+1.57%$0.73$0.71256,842 shs$60.79 million03/20/2024$0.74$0.71-3.05%$0.73$0.71233,856 shs$59.85 million03/19/2024$0.72$0.74+2.41%$0.74$0.70483,785 shs$61.73 million03/18/2024$0.72$0.72-0.14%$0.72$0.68388,553 shs$60.28 million03/15/2024$0.69$0.72+4.60%$0.73$0.68483,695 shs$60.36 million03/14/2024$0.74$0.69-7.30%$0.74$0.67529,260 shs$57.71 million03/13/2024$0.74$0.74+0.88%$0.75$0.71435,864 shs$62.25 million03/12/2024$0.79$0.74-6.89%$0.80$0.71628,853 shs$61.70 million03/11/2024$0.76$0.79+3.72%$0.79$0.75317,560 shs$66.27 million03/08/2024$0.78$0.76-2.03%$0.80$0.75514,379 shs$63.89 million03/07/2024$0.79$0.78-1.03%$0.82$0.77427,857 shs$65.22 million03/06/2024$0.80$0.79-1.39%$0.82$0.78250,533 shs$65.90 million03/05/2024$0.81$0.80-1.59%$0.81$0.75383,800 shs$66.83 million03/04/2024$0.77$0.81+5.05%$0.84$0.78731,269 shs$67.92 million03/01/2024$0.77$0.77+0.27%$0.80$0.75304,185 shs$64.65 million Related Companies: Gritstone bio Stock Chart Atea Pharmaceuticals Stock Chart Kamada Stock Chart XOMA Stock Chart ADC Therapeutics Stock Chart CorMedix Stock Chart Mersana Therapeutics Stock Chart Vanda Pharmaceuticals Stock Chart Nature's Sunshine Products Stock Chart Xeris Biopharma Stock Chart Receive HOOK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HOOK) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hookipa Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.